Price Target Changed • Jun 08
Price target decreased by 8.7% to €8.70 Down from €9.53, the current price target is an average from 3 analysts. New target price is 85% above last closing price of €4.71. Stock is up 26% over the past year. The company is forecast to post a net loss per share of €0.29 next year compared to a net loss per share of €0.93 last year. Reported Earnings • Apr 19
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: €0.93 loss per share (further deteriorated from €0.41 loss in FY 2024). Revenue: €34.9m (up 13% from FY 2024). Net loss: €19.7m (loss widened 159% from FY 2024). Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 101%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings. Price Target Changed • Mar 31
Price target decreased by 10% to €9.53 Down from €10.63, the current price target is an average from 3 analysts. New target price is 140% above last closing price of €3.98. Stock is down 4.3% over the past year. The company is forecast to post a net loss per share of €0.42 next year compared to a net loss per share of €0.41 last year. New Risk • Mar 25
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €86.3m (US$99.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€5.8m). Market cap is less than US$100m (€86.3m market cap, or US$99.7m). Announcement • Nov 22
LAIQON AG Partners with Amundi to Launch Active AI ETF for Europe in 2026 LAIQON AG announced that first active AI ETF will mark the start of a new LAIQON product family. The LAIQON Group is currently working on launching its first actively managed AI ETF in partnership with Amundi, using Amundi's ETF-as-a-Service platform. The new actively managed AI-optimized ETF will be designed to offer institutional and private investors innovative access to the growth potential of European stock markets, leveraging the proven AI technology of LAIC ADVISOR, which has been in use since 2019. LAIC ADVISOR employs a six-step, data-driven analysis and control process that combines global data sources, deep learning and factor models, and uses neural networks. This new ETF will aim to achieve long-term risk-adjusted outperformance relative to the European equity markets through the alpha potential of AI-supported portfolio management. The launch of the ETF is expected for first half of 2026, subject to regulatory approval. The ambition is to distribute the ETF in Germany and make it tradable on the usual platforms on each trading day from the start of distribution. The ETF marks the start of a planned product family, which is aimed at expanding in the future with further strategies, e.g., focusing on the US and global stock markets. As part of the partnership, the LAIQON Group will contribute its expertise in AI-supported portfolio management through its WealthTech subsidiary LAIC, while Amundi will take over the management of the ETF on its White Label and Active ETF platform, contributing its extensive experience in ETF structuring. Capital flows are shifting, new transformative industries are emerging, ESG regulations are forcing investors to adopt clear sustainability strategies, and the use of AI is fundamentally changing the financial world. The new LAIQON ETF aims at combining these trends, making it a differentiating factor in any portfolio. It also serves a segment of the rapidly growing market for active ETFs that has been largely overlooked until now. Announcement • Nov 18
Laiqon AG Announces Executive Changes The Supervisory Board of LAIQON AG has appointed Mr. Axel Hörger to the Executive Board as Chief Strategy Officer (CSTRO) with effect from January 1, 2026. Since March 2025, the former CEO of UBS Deutschland AG has been serving as Senior Advisor to the Board. Mr. Hörger succeeds Stefan Mayerhofer, who will step down from his position as Chief Wealth Officer on December 31, 2025, as planned. Mayerhofer will continue to serve selected clients as a senior advisor at BV Bayerische Vermögen GmbH and manage the Mayerhofer Strategie AMI fund. The newly formed Executive Board team, with Dipl.-Ing. Achim Plate as Chief Executive Officer (CEO) and Axel Hörger, is committed to close collaboration and shared responsibility in driving LAIQON AG’s GROWTH 28 strategy. Mr. Plate as CEO of the LAIQON Group is still responsible for the Digital Wealth business segment as well as the areas of Finance, Legal, Compliance, People & Organization, Technology, and IR/PR. As CSTRO, Mr. Hörger will be responsible for the asset and wealth management business segments as well as group sales and sustainability. He has in-depth expertise in capital markets coupled with digital and quantitative understanding. Special emphasis will be placed on strengthening collaboration with national and international partner networks in the area of sales. His parallel leadership role in the Swiss subsidiary of the LAIQON Group underscores the growing importance of the DACH region for the Group. Axel Hörger brings many years of leadership experience at international asset and wealth managers and can draw on a broad network in the industry. Most recently, he was co-founder and chairman of AIB Acquisition Cooperation, a New York-based SPAC listed on Nasdaq. Previously, he was CEO of Petiole Asset Management AG (Switzerland), CEO of Lombard International Assurance in Europe, and from 2011 to 2015 CEO of UBS Deutschland AG and head of its Wealth Management. Before that, Mr. Hörger worked for 16 years at Goldman Sachs as Managing Director, most recently as Head of Institutional Sales for EMEA in Asset Management. To this day, he is active in various advisory boards, including Siemens and Atlantik-Brücke e.V. New Risk • Oct 07
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €85.0m (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€5.8m). Market cap is less than US$100m (€85.0m market cap, or US$99.0m). Major Estimate Revision • Sep 08
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €38.4m to €37.1m. Losses expected to increase from €0.24 per share to €0.27. Capital Markets industry in Germany expected to see average net income growth of 21% next year. Consensus price target broadly unchanged at €10.40. Share price fell 8.7% to €4.64 over the past week. New Risk • Aug 31
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -€5.8m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. This is currently the only risk that has been identified for the company. Announcement • Jul 21
Laiqon AG, Annual General Meeting, Aug 28, 2025 Laiqon AG, Annual General Meeting, Aug 28, 2025, at 10:00 W. Europe Standard Time. Price Target Changed • Jul 17
Price target increased by 12% to €10.50 Up from €9.35, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €4.32. Stock is down 8.9% over the past year. The company is forecast to post a net loss per share of €0.24 next year compared to a net loss per share of €0.41 last year. Price Target Changed • Jun 27
Price target increased by 15% to €9.35 Up from €8.13, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €3.57. Stock is down 21% over the past year. The company is forecast to post a net loss per share of €0.24 next year compared to a net loss per share of €0.41 last year. Major Estimate Revision • Apr 16
Consensus EPS estimates fall by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €39.5m to €35.7m. Losses expected to increase from €0.23 per share to €0.26. Capital Markets industry in Germany expected to see average net income growth of 12% next year. Consensus price target broadly unchanged at €8.13. Share price was steady at €3.94 over the past week. New Risk • Apr 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Market cap is less than US$100m (€83.3m market cap, or US$94.4m). Reported Earnings • Apr 01
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: €0.41 loss per share (improved from €0.70 loss in FY 2023). Revenue: €31.0m (flat on FY 2023). Net loss: €7.63m (loss narrowed 38% from FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 2.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. New Risk • Dec 02
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €94.8m (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€11m). Share price has been volatile over the past 3 months (7.4% average weekly change). Shareholders have been diluted in the past year (8.9% increase in shares outstanding). Market cap is less than US$100m (€94.8m market cap, or US$99.4m). Major Estimate Revision • Sep 06
Consensus EPS estimates fall by 84% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €36.5m to €33.0m. Losses expected to increase from €0.23 per share to €0.42. Capital Markets industry in Germany expected to see average net income growth of 7.9% next year. Consensus price target down from €10.93 to €8.33. Share price fell 14% to €4.21 over the past week. Price Target Changed • Sep 02
Price target decreased by 19% to €9.10 Down from €11.17, the current price target is an average from 3 analysts. New target price is 107% above last closing price of €4.40. Stock is down 44% over the past year. The company is forecast to post a net loss per share of €0.39 next year compared to a net loss per share of €0.70 last year. Announcement • Jul 30
meine Volksbank Raiffeisenbank eG signed a letter of intent to acquire 25% stake in Bv Bayerische Vermögen GmbH from Laiqon AG (XTRA:LQAG). meine Volksbank Raiffeisenbank eG signed a letter of intent to acquire 25% stake in Bv Bayerische Vermögen GmbH from Laiqon AG (XTRA:LQAG) on July 30, 2024. The purchase and transfer agreement for the acquisition of 25% of BV GmbH is scheduled to be concluded within the next three months. The financial details of the investment have been kept confidential. As part of the deepening of the partnership agreed in the LoI, the mVBRB is to acquire a 25% stake in BV GmbH from LAIQON AG after completion of the due diligence. A first partial step of 9.9% of this is to be carried out directly. In order to complete the further 15.1% to 25% in a second partial step, the completion of an owner control procedure by the Federal Financial Supervisory Authority (BaFin) is required beforehand. Announcement • Jul 22
Laiqon AG, Annual General Meeting, Aug 29, 2024 Laiqon AG, Annual General Meeting, Aug 29, 2024, at 10:00 W. Europe Standard Time. New Risk • May 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€12m). Share price has been volatile over the past 3 months (8.3% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Major Estimate Revision • May 19
Consensus estimates of losses per share improve by 23% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from €36.9m to €38.2m. EPS estimate increased from -€0.25 per share to -€0.193 per share. Capital Markets industry in Germany expected to see average net income growth of 18% next year. Consensus price target broadly unchanged at €11.00. Share price rose 2.3% to €5.40 over the past week. Price Target Changed • Apr 19
Price target decreased by 8.2% to €11.17 Down from €12.17, the current price target is an average from 3 analysts. New target price is 126% above last closing price of €4.94. Stock is down 37% over the past year. The company is forecast to post a net loss per share of €0.25 next year compared to a net loss per share of €0.70 last year. Major Estimate Revision • Apr 19
Consensus estimates of losses per share improve by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from €36.2m to €36.9m. EPS estimate increased from -€0.28 per share to -€0.25 per share. Capital Markets industry in Germany expected to see average net income growth of 19% next year. Consensus price target down from €12.17 to €11.17. Share price fell 5.0% to €4.94 over the past week. Major Estimate Revision • Apr 09
Consensus revenue estimates fall by 15% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €42.4m to €36.2m. Forecast losses increased from -€0.11 to -€0.28 per share. Capital Markets industry in Germany expected to see average net income growth of 18% next year. Consensus price target broadly unchanged at €12.17. Share price rose 3.6% to €5.24 over the past week. Reported Earnings • Apr 01
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: €0.70 loss per share (further deteriorated from €0.67 loss in FY 2022). Revenue: €30.7m (up 43% from FY 2022). Net loss: €12.3m (loss widened 21% from FY 2022). Revenue missed analyst estimates by 8.6%. Earnings per share (EPS) also missed analyst estimates by 166%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Price Target Changed • Jan 04
Price target increased by 9.5% to €12.35 Up from €11.28, the current price target is an average from 3 analysts. New target price is 82% above last closing price of €6.80. Stock is down 8.6% over the past year. The company is forecast to post a net loss per share of €0.26 next year compared to a net loss per share of €0.67 last year. Price Target Changed • Jun 02
Price target increased by 8.0% to €11.82 Up from €10.94, the current price target is an average from 3 analysts. New target price is 51% above last closing price of €7.80. Stock is down 20% over the past year. The company is forecast to post a net loss per share of €0.26 next year compared to a net loss per share of €0.67 last year. Major Estimate Revision • Apr 08
Consensus revenue estimates fall by 17% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €39.7m to €32.8m. Forecast losses increased from -€0.032 to -€0.34 per share. Capital Markets industry in Germany expected to see average net income decline 20% next year. Consensus price target of €10.31 unchanged from last update. Share price fell 4.0% to €8.10 over the past week. Price Target Changed • Apr 06
Price target increased by 15% to €10.31 Up from €8.93, the current price target is an average from 4 analysts. New target price is 27% above last closing price of €8.10. Stock is down 16% over the past year. The company is forecast to post a net loss per share of €0.34 next year compared to a net loss per share of €0.67 last year. Reported Earnings • Apr 02
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: €0.67 loss per share (down from €0.39 profit in FY 2021). Revenue: €21.6m (down 17% from FY 2021). Net loss: €10.2m (down 297% from profit in FY 2021). Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 69%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, while revenues in the Capital Markets industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 41% per year, which means it is well ahead of earnings. Price Target Changed • Feb 20
Price target decreased by 14% to €10.18 Down from €11.88, the current price target is an average from 4 analysts. New target price is 28% above last closing price of €7.96. Stock is down 23% over the past year. The company is forecast to post a net loss per share of €0.40 compared to earnings per share of €0.39 last year. Price Target Changed • Nov 16
Price target decreased to €11.65 Down from €12.80, the current price target is an average from 4 analysts. New target price is 61% above last closing price of €7.24. Stock is down 31% over the past year. The company is forecast to post a net loss per share of €0.48 compared to earnings per share of €0.39 last year. Price Target Changed • Oct 17
Price target decreased to €11.65 Down from €12.80, the current price target is an average from 3 analysts. New target price is 102% above last closing price of €5.76. Stock is down 39% over the past year. The company is forecast to post a net loss per share of €0.51 compared to earnings per share of €0.39 last year. Major Estimate Revision • Sep 10
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 forecast for profit of -€0.04 instead of a loss of €0.02 per share previously. Revenue forecast unchanged at €33.1m. Capital Markets industry in Germany expected to see average net income growth of 12% next year. Consensus price target down from €12.80 to €12.53. Share price fell 2.9% to €6.10 over the past week. Price Target Changed • Jul 29
Price target decreased to €12.80 Down from €17.17, the current price target is an average from 3 analysts. New target price is 73% above last closing price of €7.40. Stock is down 17% over the past year. The company posted earnings per share of €0.39 last year. Major Estimate Revision • Jul 27
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from €44.0m to €35.4m. EPS estimate reaffirmed at €0.10. Net income forecast to shrink 73% next year vs 20% growth forecast for Capital Markets industry in Germany . Consensus price target down from €17.17 to €16.30. Share price fell 8.8% to €7.30 over the past week. Valuation Update With 7 Day Price Move • May 30
Investor sentiment improved over the past week After last week's 24% share price gain to €9.58, the stock trades at a forward P/E ratio of 71x. Average forward P/E is 13x in the Capital Markets industry in Germany. Total returns to shareholders of 85% over the past three years. Reported Earnings • Apr 03
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: €0.39 (up from €0.053 loss in FY 2020). Revenue: €26.1m (down 5.8% from FY 2020). Net income: €5.15m (up €5.85m from FY 2020). Profit margin: 20% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 100% compared to a 7.4% decline forecast for the funds industry in Germany. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €9.48, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 87% over the past three years. Valuation Update With 7 Day Price Move • Jan 24
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €10.70, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 13x in the Capital Markets industry in Germany. Total returns to shareholders of 128% over the past three years. Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €13.20, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 170% over the past three years. Major Estimate Revision • Nov 27
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate fell from €0.10 to €0.065. Revenue forecast unchanged from €33.4m at last update. Net income forecast to shrink 59% next year vs 11% growth forecast for Capital Markets industry in Germany . Consensus price target up from €14.47 to €16.50. Share price rose 11% to €11.75 over the past week. Price Target Changed • Sep 16
Price target increased to €14.47 Up from €12.68, the current price target is an average from 3 analysts. New target price is 45% above last closing price of €10.00. Stock is up 109% over the past year. Reported Earnings • Aug 29
First half 2021 earnings released: EPS €0.28 (vs €0.30 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €18.2m (up 195% from 1H 2020). Net income: €3.71m (up €7.64m from 1H 2020). Profit margin: 20% (up from net loss in 1H 2020). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jul 07
Price target increased to €12.68 Up from €11.45, the current price target is an average from 4 analysts. New target price is 26% above last closing price of €10.05. Stock is up 181% over the past year. Reported Earnings • Apr 04
Full year 2020 earnings released: €0.05 loss per share (vs €0.009 loss in FY 2019) The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: €27.7m (up 237% from FY 2019). Net loss: €703.0k (loss widened €610.0k from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Announcement • Jan 15
BankInvest Group, Strategic Investments A/S (CPSE:STRINV), funds managed by Lloyd Fonds AG (XTRA:L1OA), Søren Skovbølling, Michael Andersen, Morten Lindblad, Herbert Nathan, Claus Dalsgaard, Ken Jarlfort and Claus Kristiansen acquired 5.24% stake in Agillic A/S (CPSE:AGILC) from four major shareholders for DKK 10.5 million. BankInvest Group, Strategic Investments A/S (CPSE:STRINV), funds managed by Lloyd Fonds AG (XTRA:L1OA), Søren Skovbølling, Michael Andersen, Morten Lindblad, Herbert Nathan, Claus Dalsgaard, Ken Jarlfort and Claus Kristiansen (buyers) acquired 5.24% stake in Agillic A/S (CPSE:AGILC) from four major shareholders for DKK 10.5 million on January 14, 2021. Under the transaction, a total of 0.525 million shares were sold for a price of DKK 20 per share. In a related transaction, the buyers acquired 0.58 million in new shares of Agillic for DKK 11.65 million. Michael Andersen invested DKK 2 million. Through the transaction BankInvest increased its investment in Agillic. Michael Andersen will join the Board of Directors of Agillic.
BankInvest Group, Strategic Investments A/S (CPSE:STRINV), funds managed by Lloyd Fonds AG (XTRA:L1OA), Søren Skovbølling, Michael Andersen, Morten Lindblad, Herbert Nathan, Claus Dalsgaard, Ken Jarlfort, and Claus Kristiansen completed the acquisition of .24% stake in Agillic A/S (CPSE:AGILC) from four major shareholders on January 14, 2021. Price Target Changed • Jan 07
Price target raised to €9.75 Up from €8.45, the current price target is an average from 4 analysts. The new target price is 39% above the current share price of €7.00. As of last close, the stock is up 35% over the past year. Is New 90 Day High Low • Jan 06
New 90-day high: €6.95 The company is up 36% from its price of €5.10 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 7.0% over the same period. Price Target Changed • Nov 17
Price target raised to €7.58 Up from €6.88, the current price target is an average from 4 analysts. The new target price is 24% above the current share price of €6.10. As of last close, the stock is up 21% over the past year. Major Estimate Revision • Nov 14
Analysts update estimates The 2020 consensus revenue estimate increased from €15.1m to €17.3m. Earning per share (EPS) estimate was unchanged from the last update at -€0.16. The Capital Markets industry in Germany is expected to see a 14% decline in net income next year. The consensus price target of €7.15 was unchanged from the last update. Share price is up 9.0% to €6.05 over the past week. Is New 90 Day High Low • Nov 03
New 90-day high: €5.15 The company is up 13% from its price of €4.56 on 05 August 2020. The German market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share. Major Estimate Revision • Oct 24
Analysts increase EPS estimates to -€0.16 The 2020 consensus revenue estimate increased from €14.8m to €15.1m. Analysts raised their EPS forecasts from -€0.22 to -€0.16 in 2020. The Capital Markets industry in Germany is expected to see a 11% decline in net income next year. The consensus price target increased from €6.88 to €7.15. Share price stayed mostly flat at €4.84 over the past week. Is New 90 Day High Low • Oct 06
New 90-day high: €5.05 The company is up 41% from its price of €3.58 on 08 July 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.